(Q26851496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

1 reference

title

An update on Mullerian-inhibiting substance: its potential application against ovarian cancer (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Raymond R Y Wong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Michael J Worley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Yick Fu Wong

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

1 reference

6 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

Endocrine-Related Cancer

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

21

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

R227-33

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623744%20AND%20SRC:MED&resulttype=core&format=json

Timing and irreversibility of Müllerian duct inhibition in the embryonic reproductive tract of the human male

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Idiopathic thrombocytopenia associated with dysgerminoma in a patient with androgen insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

5 The in Vivo Roles of Müllerian-inhibiting Substance

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Müllerian Duct Regression in the Embryo Correlated with Cytotoxic Activity Against Human Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Professor Alfred Jost: the builder of modern sex differentiation

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Developmental expression of a candidate müllerian inhibiting substance type II receptor

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

New insights into mullerian inhibiting substance and its mechanism of action.

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1530%2FERC-14-0030

7 January 2021